ONO-6950 Phase 2a study A multicenter, double-blind, randomized parallel-group study in patients with asthma.
Phase of Trial: Phase II
Latest Information Update: 10 Jun 2017
At a glance
- Drugs Gemilukast (Primary) ; Pranlukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 22 May 2017 Status changed from active, no longer recruiting to completed.
- 08 Jun 2016 New trial record